ReviewCurrent heart failure reports2008
Integrated PET/CT in the assessment of etiology and viability in ischemic heart failure.
Review in Current heart failure reports, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 20 citations in OpenAlex.
- Cardiac and PericardialJournal of cardiovascular imaging · 2018Article
- Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease-state-of-the-evidence and clinical recommendations.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2017Article
- SPECT and PET in ischemic heart failure.Heart failure reviews · 2017Review
- The role of positron emission tomography in the evaluation of myocardial ischemia in women.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2016Review
- Review: comparison of PET rubidium-82 with conventional SPECT myocardial perfusion imaging.Clinical physiology and functional imaging · 2014Review
- Nuclear cardiology and heart failure.European journal of nuclear medicine and molecular imaging · 2009Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
About 5.3 million people in the United States -suffer from heart failure, the cause of which in many patients is atherosclerotic coronary artery disease. The clinical prognosis in patients with ischemic heart failure is worse than in those with a nonischemic etiology, but the former can potentially be improved with revascularization. Integrated positron emission tomography/computed tomography (PET/CT) scanners provide a unique opportunity for determining the cause of heart failure by integrating anatomic and functional imaging of coronary circulation and heart anatomy in a single study. Several studies have shown that a combined approach of coronary CT angiography and PET-assisted myocardial perfusion imaging can accurately -evaluate coronary artery disease as the underlying cause of chronic and new-onset heart failure. PET viability testing can reveal the amount of functional myocardium and help in selecting a therapeutic strategy in patients with heart failure. Even though properly conducted prospective randomized trials are still lacking, PET/CT may become the method of choice for initial evaluation and management of patients with heart failure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.